RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PYC Therapeutics Stock

PYC Therapeutics Employees 2024

PYC Therapeutics Employees

23

Ticker

PYC.AX

ISIN

AU000000PYC7

WKN

A0D8ZY

In 2024, PYC Therapeutics employed 23 people, a 0% change from the 23 number of employees in the previous year.

PYC Therapeutics Aktienanalyse

What does PYC Therapeutics do?

PYC Therapeutics Ltd is a biopharmaceutical company based in Sydney, Australia. The company was founded in 2017 by experienced pharmaceutical and biotech managers and currently employs over 40 employees. The history of PYC Therapeutics began with the development of a novel therapy platform called "PCytTM", which is based on the use of artificial proteins. These proteins can enhance the uptake of drugs into cells, thereby increasing the effectiveness of various medications. In 2018, PYC Therapeutics achieved a significant milestone by being included in the prestigious Accelerating Commercialisation program of the Australian government. PYC Therapeutics' business model focuses on the research and development of innovative cancer therapies and rare genetic diseases. The company strives to focus on diseases for which there is currently no effective treatment. This is intended to be achieved through partnerships, licensing, and potentially through the acquisition of companies and technologies. PYC Therapeutics shapes its processes through collaboration with experts in the fields of medicine, pharmacy, biotechnology, and chemistry. The divisions of PYC Therapeutics can be divided into the following areas of activity: drug development, platform technology, partnerships, and research and development. Under drug development, PYC Therapeutics understands the actual production of new cancer therapeutics and medications for the treatment of rare genetic diseases. The company relies on its internal research and also utilizes in-licensed technologies and acquisitions to develop novel drugs. Platform technology is a key success factor for PYC Therapeutics. The company has developed a highly effective method with PCytTM to optimize drug transport. This can significantly enhance the efficacy of medications. This technology has the potential to revolutionize the treatment of many diseases. Partnerships are an important part of PYC Therapeutics' business model. The company focuses on long-term collaborations with large pharmaceutical and biotech companies. This cooperation is intended to accelerate the development, approval, and commercialization of new medications. Research and development form the core of PYC Therapeutics' business model. The company invests significantly in the exploration of new therapeutics for cancer and rare genetic diseases. Since its inception, the company has continuously expanded its development platform and has become a key player in the industry. One of PYC Therapeutics' most important pipeline products is "PYC-06". PYC-06 is a medication developed for the treatment of acute myeloid leukemia (AML). The therapy aims to enhance the potential of chemotherapeutics by using PCytTM. The initial results of clinical studies show very promising results. Overall, PYC Therapeutics is an important player in the field of innovative cancer care and the treatment of rare genetic diseases. The company has a strong pipeline of novel therapeutics based on its PCytTM technology. PYC Therapeutics strives to improve the treatment of cancer and rare diseases and achieve a better quality of life for patients. The business model of PYC Therapeutics focuses on partnerships, innovative developments, and scientific research that contribute to advancing the industry. PYC Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining PYC Therapeutics's Employee Base

PYC Therapeutics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding PYC Therapeutics's operational capacity and future potential.

Year-to-Year Comparison

Assessing PYC Therapeutics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

PYC Therapeutics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in PYC Therapeutics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about PYC Therapeutics stock

How many employees does PYC Therapeutics have this year?

PYC Therapeutics has 23 undefined employees this year.

How many employees did PYC Therapeutics have compared to the previous year?

Compared to the previous year, PYC Therapeutics had 0% more employees.

What impact did the number of employees have on the company PYC Therapeutics?

The number of employees has a direct impact on the efficiency and productivity of PYC Therapeutics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of PYC Therapeutics?

The number of employees can also have an impact on investors of PYC Therapeutics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of PYC Therapeutics affect the company?

An increase in equity of PYC Therapeutics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in PYC Therapeutics's equity affect the company?

A reduction in equity of PYC Therapeutics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of PYC Therapeutics?

Some factors that can influence the equity of PYC Therapeutics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of PYC Therapeutics so important for investors?

The equity of PYC Therapeutics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at PYC Therapeutics influence the company?

The number of employees at PYC Therapeutics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at PYC Therapeutics evolved in recent years?

In recent years, the number of employees at PYC Therapeutics has changed by 0.

How many employees does PYC Therapeutics currently have?

PYC Therapeutics currently has 23 undefined employees.

Why is the number of employees important for investors of PYC Therapeutics?

The number of employees is important for investors of PYC Therapeutics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can PYC Therapeutics take to change the number of employees?

To change the number of employees, PYC Therapeutics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does PYC Therapeutics pay?

Over the past 12 months, PYC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PYC Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of PYC Therapeutics?

The current dividend yield of PYC Therapeutics is .

When does PYC Therapeutics pay dividends?

PYC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PYC Therapeutics?

PYC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of PYC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PYC Therapeutics located?

PYC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von PYC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PYC Therapeutics from 11/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did PYC Therapeutics pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of PYC Therapeutics in the year 2023?

In the year 2023, PYC Therapeutics distributed 0 AUD as dividends.

In which currency does PYC Therapeutics pay out the dividend?

The dividends of PYC Therapeutics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PYC Therapeutics

Our stock analysis for PYC Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PYC Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.